InvestorsHub Logo
Followers 2
Posts 736
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Monday, 05/06/2019 3:47:00 PM

Monday, May 06, 2019 3:47:00 PM

Post# of 10489
Coming soon!
the company’s first bioprinted products are expected to make it to the U.S. Food and Drug Administration (FDA) in 2020 to begin clinical testing. Development of a healthy therapeutic liver tissue patch could treat a broad range of liver diseases, according to the company, claiming it’s objective will be to implant the patch to restore function or offset the deficiencies related to the condition

https://3dprint.com/243160/organovo-bioprinting-could-be-the-new-solution-to-organ-transplantation/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONVO News